These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33491593)

  • 1. Adaptation of WHO's generic tuberculosis patient cost instrument for a longitudinal study in Africa.
    Evans D; van Rensburg C; Govathson C; Ivanova O; Rieß F; Siroka A; Sillah AK; Ntinginya NE; Jani I; Sathar F; Rosen S; Sanne I; Rachow A; Lönnroth K
    Glob Health Action; 2021 Jan; 14(1):1865625. PubMed ID: 33491593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol.
    Rachow A; Ivanova O; Wallis R; Charalambous S; Jani I; Bhatt N; Kampmann B; Sutherland J; Ntinginya NE; Evans D; Lönnroth K; Niemann S; Schaible UE; Geldmacher C; Sanne I; Hoelscher M; Churchyard G
    BMC Pulm Med; 2019 Jan; 19(1):4. PubMed ID: 30616617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey.
    Youngkong S; Kamolwat P; Wongrot P; Thavorncharoensap M; Chaikledkaew U; Nateniyom S; Pungrassami P; Praditsitthikorn N; Mahasirimongkol S; Jittikoon J; Nishikiori N; Baena IG; Yamanaka T
    Sci Rep; 2024 May; 14(1):11205. PubMed ID: 38755216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households.
    Kilale AM; Pantoja A; Jani B; Range N; Ngowi BJ; Makasi C; Majaha M; Manga CD; Haule S; Wilfred A; Hilary P; Mahamba V; Nkiligi E; Muhandiki W; Matechi E; Mutayoba B; Nishkiori N; Ershova J
    BMC Public Health; 2022 Mar; 22(1):600. PubMed ID: 35351063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study.
    Pham TAM; Forse R; Codlin AJ; Phan THY; Nguyen TT; Nguyen N; Vo LNQ; Dat PT; Minh HDT; Nguyen LH; Nguyen HB; Nguyen NV; Bodfish M; Lönnroth K; Wingfield T; Annerstedt KS
    BMC Public Health; 2023 Dec; 23(1):2372. PubMed ID: 38042797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Households experiencing catastrophic costs due to tuberculosis in Uganda: magnitude and cost drivers.
    Muttamba W; Tumwebaze R; Mugenyi L; Batte C; Sekibira R; Nkolo A; Katamba A; Kasasa S; Majwala RK; Turyahabwe S; Mugabe F; Mugagga K; Lochoro P; Dejene S; Birabwa E; Marra C; Baena IG; Kirenga B
    BMC Public Health; 2020 Sep; 20(1):1409. PubMed ID: 32938411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catastrophic Costs among Tuberculosis-Affected Households in Egypt: Magnitude, Cost Drivers, and Coping Strategies.
    Ghazy RM; Sallam M; Ashmawy R; Elzorkany AM; Reyad OA; Hamdy NA; Khedr H; Mosallam RA
    Int J Environ Res Public Health; 2023 Feb; 20(3):. PubMed ID: 36768005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia.
    Devoid I; Sillah AK; Sutherland J; Owolabi O; Ivanova O; Govathson C; Hirasen K; Davies M; Lönnroth K; Loum I; Touray A; Charlambous S; Evans D; Quaife M
    Int J Tuberc Lung Dis; 2022 Dec; 26(12):1162-1169. PubMed ID: 36447310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis.
    Getahun B; Wubie M; Dejenu G; Manyazewal T
    Infect Dis Poverty; 2016 Nov; 5(1):93. PubMed ID: 27799063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.
    van den Hof S; Collins D; Hafidz F; Beyene D; Tursynbayeva A; Tiemersma E
    BMC Infect Dis; 2016 Sep; 16(1):470. PubMed ID: 27595779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status.
    Chittamany P; Yamanaka T; Suthepmany S; Sorsavanh T; Siphanthong P; Sebert J; Viney K; Vixaysouk T; Nagai M; Seevisay V; Izumi K; Morishita F; Nishikiori N
    PLoS One; 2020; 15(11):e0241862. PubMed ID: 33180777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis.
    Akalu TY; Clements ACA; Wolde HF; Alene KA
    Sci Rep; 2023 Dec; 13(1):22361. PubMed ID: 38102144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-cost survey for tuberculosis in the context of patient-pathway modelling.
    Tomeny EM; Mendoza VL; Marcelo DB; Barrameda AJD; Langley I; Abong JM; Dalay VB; Yu CY; Squire SB
    Int J Tuberc Lung Dis; 2020 Apr; 24(4):420-427. PubMed ID: 32317067
    [No Abstract]   [Full Text] [Related]  

  • 14. The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021.
    Noia Maciel EL; Negri LDSA; Guidoni LM; Fregona GC; Johansen FDC; Sanchez MN; Moreira ADSR; Diaz-Quijano FA; Tonini M; Zandonade E; Ershova J; Nguhiu P; Baena IG
    PLoS One; 2023; 18(12):e0287961. PubMed ID: 38091306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is convenience really king? Comparative evaluation of catastrophic costs due to tuberculosis in the public and private healthcare sectors of Viet Nam: a longitudinal patient cost study.
    Nguyen HB; Vo LNQ; Forse RJ; Wiemers AMC; Huynh HB; Dong TTT; Phan YTH; Creswell J; Dang TMH; Nguyen LH; Shedrawy J; Lönnroth K; Nguyen TD; Dinh LV; Annerstedt KS; Codlin AJ
    Infect Dis Poverty; 2024 Mar; 13(1):27. PubMed ID: 38528604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socio-protective effects of active case finding on catastrophic costs from tuberculosis in Ho Chi Minh City, Viet Nam: a longitudinal patient cost survey.
    Vo LNQ; Forse RJ; Codlin AJ; Dang HM; Van Truong V; Nguyen LH; Nguyen HB; Nguyen NV; Sidney-Annerstedt K; Lonnroth K; Squire SB; Caws M; Worrall E; de Siqueira-Filha NT
    BMC Health Serv Res; 2021 Oct; 21(1):1051. PubMed ID: 34610841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of TB diagnosis and treatment in South Africa.
    Foster N; Vassall A; Cleary S; Cunnama L; Churchyard G; Sinanovic E
    Soc Sci Med; 2015 Apr; 130():42-50. PubMed ID: 25681713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India.
    Rupani MP; Cattamanchi A; Shete PB; Vollmer WM; Basu S; Dave JD
    Infect Dis Poverty; 2020 Oct; 9(1):144. PubMed ID: 33076969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and post-diagnosis costs of tuberculosis to patients on Directly Observed Treatment Short course in districts of southwestern Ethiopia: a longitudinal study.
    Asres A; Jerene D; Deressa W
    J Health Popul Nutr; 2018 May; 37(1):15. PubMed ID: 29784037
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.